Nancy De Cabooter

539 total citations
11 papers, 438 citations indexed

About

Nancy De Cabooter is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Nancy De Cabooter has authored 11 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Virology and 4 papers in Immunology. Recurrent topics in Nancy De Cabooter's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Nancy De Cabooter is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). Nancy De Cabooter collaborates with scholars based in Belgium, Mozambique and Morocco. Nancy De Cabooter's co-authors include Chris Verhofstede, Jean Plum, Filip Van Wanzeele, Bea Van Der Gucht, Els Demecheleer, Marleen Temmerman, Kim Steegen, Karim Vermaelen, Kishor Mandaliya and Bart N. Lambrecht and has published in prestigious journals such as Journal of Virology, International Journal of Cancer and AIDS.

In The Last Decade

Nancy De Cabooter

11 papers receiving 424 citations

Peers

Countries citing papers authored by Nancy De Cabooter

Since Specialization

Citations

This map shows the geographic impact of Nancy De Cabooter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy De Cabooter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy De Cabooter more than expected).

Fields of papers citing papers by Nancy De Cabooter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy De Cabooter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy De Cabooter. The network helps show where Nancy De Cabooter may publish in the future.

Co-authorship network of co-authors of Nancy De Cabooter

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy De Cabooter. A scholar is included among the top collaborators of Nancy De Cabooter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy De Cabooter. Nancy De Cabooter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA–loaded dendritic cells for cancer vaccination 2018 ·Cytotherapy ·(unknown), (unknown), Steven Smet, (unknown), (unknown), Nancy De Cabooter, Veronique Debacker, Mélissa Dullaers, Jan P. van Meerbeeck, Bart Vandekerckhove, Karim Vermaelen	9
2	The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome 2016 ·OncoImmunology ·(unknown), (unknown), Celine Everaert, Nancy De Cabooter, (unknown), Kim Deswarte, Manon Vanheerswynghels, Sofie De Prijck, (unknown), Mélissa Dullaers, Hamida Hammad, Olivier De Wever, Pieter Mestdagh, Jo Vandesompele, Bart N. Lambrecht, Karim Vermaelen	52
3	Abstract A091: Specific myelomonocytic cells heavily infiltrate orthotopic lung tumors and display a hypoxia-driven miRNA expression signature that directs tumor-supporting functions and negatively impacts on clinical outcome 2016 ·Cancer Immunology Research ·(unknown), (unknown), Celine Everaert, Simon J. Tavernier, (unknown), Nancy De Cabooter, (unknown), Kim Deswarte, Hamida Hammad, Olivier De Wever, Jo Vandesompele, Bart N. Lambrecht, Pieter Mestdagh, Karim Vermaelen	1
4	Lung tumours reprogram pulmonary dendritic cell immunogenicity at the microRNA level 2014 ·International Journal of Cancer ·(unknown), Pieter Mestdagh, Karl Vergote, Nancy De Cabooter, Jo Vandesompele, Bart N. Lambrecht, Karim Vermaelen	28
5	Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings 2007 ·Journal of Virological Methods ·Kim Steegen, Stanley Lüchters, Nancy De Cabooter, (unknown), Kishor Mandaliya, Jean Plum, Walter Jaoko, Chris Verhofstede, Marleen Temmerman	34
6	A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance 2005 ·Journal of Virological Methods ·Kim Steegen, Els Demecheleer, Nancy De Cabooter, (unknown), Marleen Temmerman, Peter M. Ndumbe, Kishor Mandaliya, Jean Plum, Chris Verhofstede	41
7	Drug-Resistant Variants That Evolve During Nonsuppressive Therapy Persist in HIV-1–Infected Peripheral Blood Mononuclear Cells After Long-Term Highly Active Antiretroviral Therapy 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Chris Verhofstede, (unknown), Els Demecheleer, Nancy De Cabooter, Filip Van Wanzeele, Bea Van Der Gucht, Dirk Vogelaers, Jean Plum	50
8	Diversity of the Human Immunodeficiency Virus Type 1 (HIV-1) env Sequence after Vertical Transmission in Mother-Child Pairs Infected with HIV-1 Subtype A 2003 ·Journal of Virology ·Chris Verhofstede, Els Demecheleer, Nancy De Cabooter, Philippe Gaillard, Fabian Mwanyumba, Patricia Claeys, Varsha Chohan, Kishorchandra Mandaliya, Marleen Temmerman, Jean Plum	57
9	Retrospective analysis of therapy response to the initial therapy in 91 treatment-naive HIV-1 patients with and without baseline resistance mutations as measured by LiPA 2001 ·Antiviral Therapy ·Kristien Van Vaerenbergh, (unknown), Inge Derdelinckx, Nancy De Cabooter, K. De Smet, Katrien Fransen, D. Marissens, Katherine M. Miller, Gaëtan Muyldermans, S Sprecher, D. Vaira, Chris Verhofstede, Georges Zissis, Marc Van Ranst, Erik De Clercq, Anne–Mieke Vandamme	1
10	Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium 2001 ·Antiviral Therapy ·Kristien Van Vaerenbergh, (unknown), Nancy De Cabooter, (unknown), K. Desmet, Katrien Fransen, Bart Maes, D. Marissens, Katherine M. Miller, Gaëtan Muyldermans, S Sprecher, Lieven Stuyver, D. Vaira, Chris Verhofstede, Georges Zissis, Marc Van Ranst, Erik De Clercq, Jan Desmyter, Anne–Mieke Vandamme	36
11	Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype 1999 ·AIDS ·Chris Verhofstede, Filip Van Wanzeele, Bea Van Der Gucht, Nancy De Cabooter, Jean Plum	129

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact